 | Up a level |
Abdulsamad, Saud A, Naeem, Abdulghani A, Zeng, Hao, He, Gang, Jin, Xi, Alenezi, Bandar A, Ai, Jianzhong, Zhang, Jiacheng, Ma, Hongwen, Rudland, Philip S 
ORCID: 0000-0002-7491-0846 et al (show 1 more authors)
(2024)
Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use.
American journal of cancer research, 14 (1).
pp. 300-323.
Naeem, Abdulghani A, Abdulsamad, Saud A, Zeng, Hao, He, Gang, Jin, Xi, Zhang, Jiacheng, Alenezi, Bandar T, Ma, Hongwen, Rudland, Philip S ORCID: 0000-0002-7491-0846 and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2024)
FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
International journal of oncology, 64 (2).
18-.
Ke, Youqiang ORCID: 0000-0001-5341-8644, Jin, Xi, Al-Bayati, Asmaa, He, Gang, Zhang, Jiachen and Wei, Qiang
(2021)
Fatty Acid-Binding Proteins and Their Roles in Disease and Cancer.
Open Access Journal Of Oncology and Medicine.
Alenezi, Bandar T, Alsubhi, Mohammed H, Jin, Xi, He, Gang, Wei, Qiang and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2021)
Global Development on Causes, Epidemiology, Aetiology, and Risk Factors of Prostate Cancer: An Advanced Study.
Highlights on Medicine and Medical Science, 17.
pp. 94-117.
Zhang, Jiacheng, He, Gang, Jin, Xi, Alenezi, Bandar T, Naeem, Abdulghani A, Abdulsamad, Saud A and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2023)
Molecular mechanisms on how FABP5 inhibitors promote apoptosis-induction sensitivity of prostate cancer cells.
Cell biology international, 47 (5).
pp. 929-942.
Jin, Xi, Aleniza, Bandar T, He, Gang, Ma, Hongwen, Wei, Qiang and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2021)
Peroxisome Proliferator-Activated Receptor Gamma
(Pparγ) and Prostate Cancer.
Journal of Oncology And Medicine.